Evidence map›Paper›PMID 31998248›Full record

ReviewFrontiers in microbiology2019

Clinical Impact of Antibiotics for the Treatment of

Elodie Olivares, Stéphanie Badel-Berchoux, Christian Provot, Gilles Prévost, Thierry Bernardi, François Jehl

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 187 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. mBio · 2025
    Article
  8. Article
  9. Article
  10. New BacteriophageViruses · 2025
    Article
  11. Chronic wounds and adaptiveCurrent research in microbial sciences · 2025
    Article
  12. Clinical relevance of Pseudomonas aeruginosa viable but non-culturable forms in cystic fibrosis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. The Anti-Microbial Peptide Citrocin ControlsInternational journal of molecular sciences · 2024
    Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elodie OlivaresUniversity of Strasbourg, CHRU Strasbourg, Fédération de Médecine Translationnelle de Strasbourg, EA7290, Institut de Bactériologie, Strasbourg, France.
Stéphanie Badel-BerchouxBioFilm Control SAS, Saint-Beauzire, France.
Christian ProvotBioFilm Pharma SAS, Saint-Beauzire, France.
Gilles PrévostUniversity of Strasbourg, CHRU Strasbourg, Fédération de Médecine Translationnelle de Strasbourg, EA7290, Institut de Bactériologie, Strasbourg, France.
Thierry BernardiBioFilm Pharma SAS, Saint-Beauzire, France.
François JehlUniversity of Strasbourg, CHRU Strasbourg, Fédération de Médecine Translationnelle de Strasbourg, EA7290, Institut de Bactériologie, Strasbourg, France.
Université de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial biofilms are highly recalcitrant to antibiotic therapies due to multiple tolerance mechanisms. The involvement of

Indexed as

antibiofilmogramantibiotic tolerancebiofilm-related infectionsbiofilmsclinical laboratory techniqueMBEC assayPseudomonas aeruginosa

Identifiers

PMID31998248
PMCPMC6962142
OpenAlexW3000314582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.